Results 151 to 160 of about 9,772 (228)

Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy. [PDF]

Neurol Sci
Barbanti P, Tassorelli C, Vernieri F, De Cesaris F, De Icco R, Di Lorenzo C, Finocchi C, Grazzi L, Guerzoni S, Mampreso E, Mastronuzzi T, Messina R, Ornello R, Rao R, Taddeo D, De Tommaso M, Rainero I.   +16 more
europepmc   +1 more source

Letter to the Editor: Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy. [PDF]

Eur J Neurol
Gaul C, Naegel S.
europepmc   +1 more source

Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study. [PDF]

J Headache Pain
Lanteri-Minet M, Casarotto C, Bretin O, Collin C, Gugenheim M, Raclot V, Cases A, Squara PA, Aissani W, Saighi A, Lefebvre H.   +10 more
europepmc   +1 more source

Association between triptan use and ischemic events in patients with ischemic risk factors: A meta-analysis. [PDF]

Saudi Med J
Aldehaim FM, Alruways AA, Alfarhan AA, Almunyif SN, Alhusainy AZ, Albahli OH, Almutairi BA, Alotaibi MM, Alotaibi AM, Alotaibi AE, Aldalbahi SS, Shabbir M, Alammar MA.   +12 more
europepmc   +1 more source

Cardiovascular risk and triptan usage among patients with migraine. [PDF]

Headache
Peles I, Shneyour RS, Levanon E, Steen YM, Abu Salameh I, Gordon M, Abuhasira R, Novack V, Ifergane G.   +8 more
europepmc   +1 more source

Patient-centered outcomes in the acute treatment of migraine: a prospective, real-world, longitudinal survey study (UNIVERSE II) comparing migraine patients who switch from a prior triptan to another triptan or ubrogepant. [PDF]

Pain Manag
Lipton RB, Bodhani A, Gao X, Duan M, Wilson L, Cadiou F, Gandhi P, Jariwala-Parikh K.   +7 more
europepmc   +1 more source

Acephalgic Migraine Presenting as Episodic Fatigue and Nausea: A Case Report. [PDF]

Clin Med Res
Oliveira DG.
europepmc   +1 more source

Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents. [PDF]

Headache
Tourlas K, Ilangovan S, White C, Irwin SL, Pavitt S.   +4 more
europepmc   +1 more source

Evaluating Triptan Safety in Pediatric Migraine Management: A Comprehensive Pharmacovigilance Analysis. [PDF]

J Pain Res
Chen J, Huang S, Chen Y, Luo C, Li Y.
europepmc   +1 more source